Tatjana Arsenijevic

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jean‐Luc Van Laethem · 13 shared papers, 2021–2026 · strength 2.19
   • Paper No evidence for the presence and control of tumor growth by cytoplasmic stress granules in pancreatic cancer DOI 10.1101/2023.11.13.566518↗
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Ana… DOI 10.3390/biomedicines12030591↗
2. Christelle Bouchart · 10 shared papers, 2021–2026 · strength 1.91
   • Paper No evidence for the presence and control of tumor growth by cytoplasmic stress granules in pancreatic cancer DOI 10.1101/2023.11.13.566518↗
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Ana… DOI 10.3390/biomedicines12030591↗
3. Julie Navez · 7 shared papers, 2023–2026 · strength 1.37
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Ana… DOI 10.3390/biomedicines12030591↗
   • Paper A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in … DOI 10.3390/cells13010003↗
4. Oier Azurmendi Senar · 7 shared papers, 2023–2026 · strength 1.34
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Ana… DOI 10.3390/biomedicines12030591↗
   • Paper A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in … DOI 10.3390/cells13010003↗
5. Rémy Nicolle · 8 shared papers, 2021–2026 · strength 1.22
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Panc… DOI 10.1101/2025.07.07.663493↗
   • Paper High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in panc… DOI 10.1002/path.6212↗
6. Kosta Stosic · 5 shared papers, 2023–2026 · strength 1.00
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Ana… DOI 10.3390/biomedicines12030591↗
   • Paper A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in … DOI 10.3390/cells13010003↗
7. Pieter Demetter · 5 shared papers, 2021–2026 · strength 0.92
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Panc… DOI 10.1101/2025.07.07.663493↗
   • Paper Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic duc… DOI 10.1093/bjsopen/zrae134↗
8. Nicky D’Haene · 5 shared papers, 2021–2026 · strength 0.87
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic duc… DOI 10.1093/bjsopen/zrae134↗
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Ster… DOI 10.1101/2024.04.30.591890↗
9. Jean‐Baptiste Bachet · 5 shared papers, 2021–2026 · strength 0.71
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
   • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Ster… DOI 10.1101/2024.04.30.591890↗
   • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
10. Ilse Rooman · 3 shared papers, 2024–2026 · strength 0.55
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
    • Paper High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in panc… DOI 10.1002/path.6212↗
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Ster… DOI 10.1101/2024.04.30.591890↗
11. Jerome F. Cros · 4 shared papers, 2021–2025 · strength 0.53
    • Paper Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Panc… DOI 10.1101/2025.07.07.663493↗
    • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
12. Francesco Puleo · 4 shared papers, 2021–2022 · strength 0.48
    • Paper Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind. DOI 10.3390/cancers13061231↗
    • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
13. Ellis Michiels · 2 shared papers, 2024–2026 · strength 0.39
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
    • Paper High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in panc… DOI 10.1002/path.6212↗
14. Léo Mas · 2 shared papers, 2024–2026 · strength 0.38
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Ster… DOI 10.1101/2024.04.30.591890↗
15. Shulin Zhao · 2 shared papers, 2024–2026 · strength 0.38
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Ster… DOI 10.1101/2024.04.30.591890↗
16. Matthieu Hein · 2 shared papers, 2024–2026 · strength 0.38
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-… DOI 10.1038/s41416-025-03274-0↗
    • Paper Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Ster… DOI 10.1101/2024.04.30.591890↗
17. Nelson Dusetti · 3 shared papers, 2021–2024 · strength 0.37
    • Paper High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in panc… DOI 10.1002/path.6212↗
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
18. Akeila Bellahcène · 2 shared papers, 2023–2025 · strength 0.35
    • Paper Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Panc… DOI 10.1101/2025.07.07.663493↗
    • Paper Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. DOI 10.3390/cells12101414↗
19. Rebekah Crake · 2 shared papers, 2023–2025 · strength 0.35
    • Paper Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Panc… DOI 10.1101/2025.07.07.663493↗
    • Paper Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. DOI 10.3390/cells12101414↗
20. Magali Svrcek · 3 shared papers, 2021–2022 · strength 0.33
    • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
21. Pascal R. Hammel · 3 shared papers, 2021–2022 · strength 0.33
    • Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
22. Maxime Libert · 1 shared paper, 2023 · strength 0.22
    • Paper No evidence for the presence and control of tumor growth by cytoplasmic stress granules in pancreatic cancer DOI 10.1101/2023.11.13.566518↗
23. Patrick Jacquemin · 1 shared paper, 2023 · strength 0.22
    • Paper No evidence for the presence and control of tumor growth by cytoplasmic stress granules in pancreatic cancer DOI 10.1101/2023.11.13.566518↗
24. Rita Saúde-Conde · 1 shared paper, 2024 · strength 0.22
    • Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Ana… DOI 10.3390/biomedicines12030591↗
25. Julie Roques · 2 shared papers, 2021–2022 · strength 0.21
    • Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
    • Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.